受下半年拖累,绿叶制药去年全年营利双降 核心产品销售全线下滑

读创客户端
30 Mar

3月30日晚间,绿叶制药(02186)发布截至2024年12月31日止年度的业绩公告。公司在报告期内实现收入约为60.61亿元,较截至2023年12月31日止年度收入减少约8170万元,降幅为1.3%;股东应占溢利4.72亿元,同比减少11.4%。事实上,绿叶制药2024年上半年表现出色,收入30.75亿元,同比增加约1.7亿元;股东应占溢利为3.88亿元,同比增长158.5%。如此算来,公司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10